CAU
SNDX icon

Caxton Associates (UK)’s Syndax Pharmaceuticals SNDX Stock Holding History

Caxton Associates (UK)’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,945
Closed -$257K – 899
2025
Q1 		$257K Buy
+20,945
New +$257K 0.01% 660